Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Geriatric Nursing (New York, N.Y.)|May 1, 1985
Alzheimer's disease. Drug therapiesN R Cutler, P K Narang
Comprehensive Psychiatry|March 1, 1982
Life course of illness in untreated manic-depressive patientsN R Cutler, R M Post
JAMA|November 17, 1978
The tricyclic antidepressantsN R Cutler, J F Heiser
The American Journal of Psychiatry|March 1, 1977
A positive response to rapid treatmentN R Cutler, D J Anderson
Revue Neurologique|December 3, 1998
Exploratory studies: implications for drug development in Alzheimer's diseaseN R Cutler, J J Sramek
Expert Opinion on Investigational Drugs|November 4, 2000
Ongoing trials in Alzheimer's diseaseJ J Sramek, N R Cutler
The Psychiatric Clinics of North America|December 1, 1984
Implications of dosing tricyclic antidepressants and benzodiazepines in geriatricsN R Cutler, P K Narang
JAMA|December 28, 1979
Leukopenia following treatment with thiothixene and haloperidolN R Cutler, J F Heiser
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Pharmacotherapy in Alzheimer's disease: basis and rationaleP K Narang, N R Cutler
Alzheimer Disease and Associated Disorders|February 24, 2001
RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?J J Sramek, N R Cutler
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Geriatric Nursing (New York, N.Y.)|May 1, 1985
Alzheimer's disease. Drug therapiesN R Cutler, P K Narang
Comprehensive Psychiatry|March 1, 1982
Life course of illness in untreated manic-depressive patientsN R Cutler, R M Post
JAMA|November 17, 1978
The tricyclic antidepressantsN R Cutler, J F Heiser
The American Journal of Psychiatry|March 1, 1977
A positive response to rapid treatmentN R Cutler, D J Anderson
Revue Neurologique|December 3, 1998
Exploratory studies: implications for drug development in Alzheimer's diseaseN R Cutler, J J Sramek
Expert Opinion on Investigational Drugs|November 4, 2000
Ongoing trials in Alzheimer's diseaseJ J Sramek, N R Cutler
The Psychiatric Clinics of North America|December 1, 1984
Implications of dosing tricyclic antidepressants and benzodiazepines in geriatricsN R Cutler, P K Narang
JAMA|December 28, 1979
Leukopenia following treatment with thiothixene and haloperidolN R Cutler, J F Heiser
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Pharmacotherapy in Alzheimer's disease: basis and rationaleP K Narang, N R Cutler
Alzheimer Disease and Associated Disorders|February 24, 2001
RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?J J Sramek, N R Cutler
Pageof 17